Shares of Acorda Therapeutics, Inc. (Nasdaq: ACOR) are fractionally higher today today despite a lackluster new "Hold" rating at Citigroup.

The ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE